Pei Wei

Dr. Pei Wei


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2019 in Medical Science Monitor
Verified
Journal Article
Closed access
PDF file
RZRui Zhang
Rui Zhang
ZCZhi Chen
Zhi Chen
SWShu-Sheng Wu
Shu-Sheng Wu
JXJun Xu
Jun Xu
LKLing-Chun Kong
Ling-Chun Kong
PWPei Wei
Pei Wei
BACKGROUND:Sorafenib, a multiple-target-point kinase inhibitor, has been used as a standard treatment for advanced liver cancer and has shown therapeutic benefits. However, resistance often occurs, prompting the need for identification of synergizing...

23 April 2024 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
ZWZhiyong Wang
Zhiyong Wang
JLJiaqi Li
Jiaqi Li
JGJinjin Guo
Jinjin Guo
PWPei Wei
Pei Wei

13 December 2023 in Inflammation Research
Verified
Journal Article
Closed access
PDF file
ZWZhiyong Wang
Zhiyong Wang
MWMin Wang
Min Wang
MLMao Lin
Mao Lin
PWPei Wei
Pei Wei

17 July 2019 in Basic & Clinical Pharmacology & Toxicology
Verified
Journal Article
Open access
PDF file
ZWZhiyong Wang
Zhiyong Wang
HXHuan Xu
Huan Xu
JZJunai Zhang
Junai Zhang
HJHua Jin
Hua Jin
PWPei Wei
Pei Wei
Basic fibroblast growth factor (bFGF) can stimulate cancer cell growth and invasion; however, the influence of bFGF blockade remains unclear. Therefore, we aimed to explore the effects of bFGF blockade on the growth and invasion in A549 (high bFGF expression) and H2122 (low bFGF expression) lung cancer cells. We found that the blocking of bFGF by a neutralizing monoclonal antibody suppressed the growth of A549 cells but not of H2122 cells, as well as strongly induced the invasiveness of A549 cancer cells. Furthermore, bFGF blockade activated the AKT pathway and enhanced the expression levels of matrix metalloproteinase (MMP)‐2 and vascular endothelial growth factor (VEGF) in A549 cells. These responses could be reversed by treatment with AKT inhibitor and siMMP‐2, thus indicating the involvement of the AKT/MMP‐2/VEGF‐positive feedback loop. Finally, we confirmed that the anti‐bFGF‐induced invasion of cancer cells could be rescued by inhibiting the AKT/MMP‐2/VEGF loop. Our results revealed that bFGF blockade suppresses cell growth but promotes cell invasion in lung cancer cells with high bFGF expression levels. Our data further reinforced the importance of the AKT/MMP‐2/VEGF loop in regulating anti‐bFGF‐induced tumour cell invasion and suggested the limitations of the bFGF‐targeting strategy in lung cancer treatment.

3 January 2024 in Frontiers in Immunology
Verified
Journal Article
Open access
ZWZhiyong Wang
Zhiyong Wang
PWPei Wei
Pei Wei
In this review article, we explore the characteristics of RNA viruses and their potential threats to humanity. We also provide a brief overview of the primary contemporary techniques used for the early detection of such viruses. After thoroughly analyzing the strengths and limitations of these methods, we highlight the importance of integrating nucleic acid testing with immunological assays in RNA virus detection. Although notable methodological differences between nucleic acid testing and immune assays pose challenges, the emerging single-molecule immunoassay-digital ELISA may be applied to technically integrate these techniques. We emphasize that the greatest value of digital ELISA is its extensive compatibility, which creates numerous opportunities for real-time, large-scale testing of RNA viruses. Furthermore, we describe the possible developmental trends of digital ELISA in various aspects, such as reaction carriers, identification elements, signal amplification, and data reading, thus revealing the remarkable potential of single-molecule digital ELISA in future RNA virus detection.

9 January 2024 in Frontiers in Cell and Developmental Biology
Verified
Journal Article
Open access
ZWZhiyong Wang
Zhiyong Wang
MWMin Wang
Min Wang
XZXuan Zeng
Xuan Zeng
XYXupeng Yue
Xupeng Yue
PWPei Wei
Pei Wei
This review presents the advancements in nanomaterial (NM)-induced pyroptosis in specific types of cells. We elucidate the relevance of pyroptosis and delineate its mechanisms and classifications. We also retrospectively analyze pyroptosis induced by various NMs in a broad spectrum of non-tumorous cellular environments to highlight the multifunctionality of NMs in modulating cell death pathways. We identify key knowledge gaps in current research and propose potential areas for future exploration. This review emphasizes the need to focus on less-studied areas, including the pathways and mechanisms of NM-triggered pyroptosis in non-tumor-specific cell types, the interplay between biological and environmental factors, and the interactions between NMs and cells. This review aims to encourage further investigations into the complex interplay between NMs and pyroptosis, thereby providing a basis for developing safer and more effective nanomedical therapeutic applications.